Cynomolgus CD80 Protein, His Tag
-
产品编号
KMP2334
-
别名
T淋巴细胞活化抗原CD80, T-lymphocyte activation antigen CD80, Activation B7-1 antigen
-
规格
- 50ug
- 100ug
- 200ug
| Catalog Number | KMP2334 |
| Alias | T淋巴细胞活化抗原CD80, T-lymphocyte activation antigen CD80, Activation B7-1 antigen |
| Size | 50ug, 100ug, 200ug |
| Product Description | The Cynomolgus CD80 Protein(KMP2334) is produced in HEK293 Cells and the target gene encoding Val35-Asn242 is expressed with a 6His tag at the C-terminus. |
| Molecular Name | CD80 |
| Product Introduction | CD80(B7-1):免疫球蛋白超家族跨膜蛋白,作为CD28/CTLA-4的配体,在抗原呈递细胞表面表达。 |
| Molecular Weight | 23.54 kDa |
| Expression System | HEK293 Cells |
| Species | Cynomolgus |
| Purity | >95% |
| SDS-PAGE | ![]() |
| Purification | Affinity Purification |
| Uniprot ID | G7NXN7 |
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.4 |
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. |
| Background | Cynomologous Cluster of Differentiation 80, also called B7-1, is a member of cell surface immunoglobulin superfamily.It is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells.CD80 plays key, yet distinct roles in the activation of T cells. B7-1/CD80 and B7-2/CD86, together with their receptors CD28 and CTLA4, constitute one of the dominant co-stimulatory pathways that regulate T- and B- cell responses. CD80 is mostly expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas. |
| Endotoxin | <1.0 EU/ug determined by the LAL method |
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 |
可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。
常用的纯化方法包括亲和层析(如His-Tag、GST-Tag)、离子交换层析、疏水相互作用层析(HIC)和凝胶过滤层析。具体方法取决于蛋白特性和标签类型。
0